[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Biopharma_Watch Avatar @Biopharma_Watch BiopharmaWatch

BiopharmaWatch posts on X about $bjdx, nasdaq, ticker, pricing the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks XXXX% finance XXXX% cryptocurrencies XXXX% exchanges XXX% technology brands XXX% countries XXX%

Social topic influence $bjdx #52, nasdaq #1138, ticker 0.6%, pricing #233, $sttk 0.4%, $lyra #15, $dyn 0.4%, $apm #11, $ganx #1, $ngne XXX%

Top accounts mentioned or mentioned by @randylus @olddogwthnwtrix @goderguy @maximusholla @aponiaanalytics @boudin420 @monacobiotech @parasbiotech @solafsson @bkfviking123 @jq1234t @alerts_bullish

Top assets mentioned LYRA (LYRA) Dyne Therapeutics, Inc. Common Stock (DYN) apM Coin (APM) Bruker, Corp. (BRKR) Arcblock (ABT) Inspect (INSP) Tourmaline Bio, Inc. Common Stock (TRML) Bonpay (BON) Vera Therapeutics, Inc. Class A Common Stock (VERA) Avidity Biosciences, Inc. Common Stock (RNA) Pfizer, Inc. (PFE) Apogee Therapeutics, Inc. Common Stock (APGE) DENTSPLY SIRONA Inc (XRAY)

Top Social Posts #

Top posts by engagements in the last XX hours

"Top Market Movers: Positive News Full Access: $NGNE 29.10$ XXXXX% October X 2025 Neurogene to Participate in H.C. Wainwright Genetic Medicines Virtual Conference"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XXX engagements

"Latest catalysts: $TNXP Catalyst Date - 2025-10-15 Drug - TNX-801 (Mpox Vaccine) Treatment - Mpox Smallpox"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1116 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $BRKR 29.35$ -XXXXX% September X 2025 Bruker Announces Pricing of Public Offering of $XXX Million of XXXXX% Mandatory Convertible Preferred Stock"
X Link @Biopharma_Watch 2025-09-04T13:38Z 1115 followers, XXX engagements

"Top Market Movers: Positive News Full Access: $BJDX 3.74$ XXXXX% October XX 2025 Bluejay Diagnostics Announces Closing of $XXX Million Private Placement Priced At-The-Market Under Nasdaq Rules"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1116 followers, XXX engagements

"$BJDX 2.86$ -XXXXX% October XX 2025 Bluejay Diagnostics Announces $XXX Million Private Placement Priced At-the-Market Under Nasdaq Rules"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1115 followers, XXX engagements

"$EYPT 12.00$ -XXXX% October XX 2025 EyePoint Announces Pricing of Public Offering"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1116 followers, XX engagements

"$STTK 2.46$ XXXX% October X 2025 Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel"
X Link @Biopharma_Watch 2025-10-03T15:45Z 1115 followers, XXX engagements

"Latest catalysts: $STTK Catalyst Date - 2025-10-08 Drug - SL-325 (Death Receptor X blocking antibody) Treatment - Inflammatory bowel disease (IBD) inflammatory and immune-related diseases"
X Link @Biopharma_Watch 2025-10-08T15:45Z 1115 followers, XXX engagements

"$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XX engagements

"Top Market Movers: Negative News Full Access: $QNRX 16.54$ -XXXXX% October XX 2025 Quoin Pharmaceuticals Announces Private Placement Financing of Up to $XXXXX Million"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XXX engagements

"$OCUL Catalyst Date - 2025-10-16 Drug - AXPAXLI (OTX-TKI) Treatment - wet age-related macular degeneration (wet AMD)"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1116 followers, XXX engagements

"$DYN Catalyst Date - 2025-10-08 Drug - zeleciment basivarsen (z-basivarsen formerly known as DYNE-101) Treatment - myotonic dystrophy type X (DM1)"
X Link @Biopharma_Watch 2025-10-08T15:45Z 1116 followers, XX engagements

"$APM 1.45$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $ANRO - 496.2K - 12.4M - XXXXX $OVID - 3.1M - 35.3M - XXXXX $NAII - 7.3K - 19.3K - 2.64"
X Link @Biopharma_Watch 2025-10-03T15:45Z 1115 followers, XXX engagements

"$ABT 127.61$ -XXXX% October XX 2025 Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1116 followers, XX engagements

"Top Market Movers: Positive News Full Access: $CGEM 7.84$ XXXX% October XX 2025 Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XXX engagements

"$INSP 77.05$ XXXX% October XX 2025 Inspire Medical Systems Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $BCAX 17.11$ -XXXX% October XX 2025 Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1116 followers, XX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $BON - 1.5M - 41.1M - XXXXX $TRML - 486.6K - 8.0M - XXXXX $XLO - 629.4K - 6.3M - 9.98"
X Link @Biopharma_Watch 2025-09-09T15:45Z 1115 followers, XXX engagements

"$GANX Catalyst Date - 2025-10-14 Drug - GT-02287 (allosteric enzyme modulator) Treatment - Parkinson's disease (PD) with or without a GBA1 mutation"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $GTBP 0.74$ -XXXXX% October X 2025 GT Biopharma Provides Enrollment Update on GTB-3650 Phase X Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Ma"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $SSKN 1.91$ -XXXXX% October XX 2025 Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma Mycosis Fungoides"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1116 followers, XX engagements

"Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1116 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $ACTU 6.97$ -XXXXX% September XX 2025 Actuate Therapeutics Announces Proposed Public Offering of Common Stock"
X Link @Biopharma_Watch 2025-09-10T15:45Z 1115 followers, XXX engagements

"$ACXP 7.40$ -XXXX% October XX 2025 Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XX engagements

"$BJDX 2.86$ -XXXXX% October XX 2025 Bluejay Diagnostics Announces Closing of $XXX Million Private Placement Priced At-The-Market Under Nasdaq Rules"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1115 followers, XX engagements

"Latest catalysts: $GANX Catalyst Date - 2025-10-14 Drug - GT-02287 (allosteric enzyme modulator) Treatment - Parkinson's disease (PD) with or without a GBA1 mutation"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1116 followers, XXX engagements

"Latest catalysts: $GHRS Catalyst Date - 2025-10-13 Drug - GH001 (mebufotenin) Treatment - Treatment-resistant depression (TRD)"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XXX engagements

"$SYRE 20.69$ XXXX% October XX 2025 Spyre Therapeutics Announces Pricing of $XXXXX Million Public Offering of Common Stock"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1116 followers, XX engagements

"Latest catalysts: $VERA Catalyst Date - 4Q 2025 Drug - Atacicept Treatment - IgAN (Immunoglobulin A Nephropathy)"
X Link @Biopharma_Watch 2025-10-01T15:45Z 1115 followers, XXX engagements

"Latest catalysts: $RVPH Catalyst Date - 2025-10-10 Drug - brilaroxazine (RP5063) Treatment - schizophrenia"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1115 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $ENVB 0.70$ -XXXXX% October X 2025 Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials"
X Link @Biopharma_Watch 2025-10-03T15:45Z 1115 followers, XXX engagements

"$RNA 46.84$ -XXXX% October XX 2025 Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1116 followers, XXX engagements

"Latest catalysts: $SGMT Catalyst Date - 2025-10-09 Drug - denifanstat (selective FASN inhibitor) Treatment - metabolic dysfunction associated steatohepatitis (MASH)"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XXX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $TCRT - 735.5K - 20.6M - XXXXX $ATHE - 140.6K - 3.7M - XXXXX $BDRX - 176.7K - 4.0M - 22.51"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XXX engagements

"$PFE 26.98$ XXXX% October XX 2025 Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025"
X Link @Biopharma_Watch 2025-10-01T15:45Z 1115 followers, XX engagements

"$DYN 12.65$ XXXX% September XX 2025 Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy"
X Link @Biopharma_Watch 2025-09-30T15:45Z 1112 followers, XX engagements

"$APGE 51.65$ XXXX% October X 2025 Apogee Therapeutics Inc. Announces Pricing of $XXX Million Underwritten Public Offering"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XX engagements

"$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1115 followers, XXX engagements

"$XRAY 12.68$ -XXXX% October X 2025 Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization"
X Link @Biopharma_Watch 2025-10-06T15:45Z 1116 followers, XXX engagements

"Top Market Movers: Positive News Full Access: $ADXN 10.17$ XXXXX% September XX 2025 Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update"
X Link @Biopharma_Watch 2025-09-30T15:45Z 1115 followers, XXX engagements